Advanced

Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation: results on health-related quality of life and symptom burden. The MANTRA-PAF trial.

Walfridsson, H; Walfridsson, U; Nielsen, J Cosedis; Johannessen, A; Raatikainen, P; Janzon, M; Levin, L A; Aronsson, M; Hindricks, G and Kongstad Rasmussen, Ole LU , et al. (2015) In Europace 17(2). p.215-221
Abstract
The Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Paroxysmal Atrial Fibrillation (MANTRA-PAF) trial assessed the long-term efficacy of an initial strategy of radiofrequency ablation (RFA) vs. antiarrhythmic drug therapy (AAD) as first-line treatment for patients with PAF. In this substudy, we evaluated the effect of these treatment modalities on the Health-Related Quality of Life (HRQoL) and symptom burden of patients at 12 and 24 months.
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Europace
volume
17
issue
2
pages
215 - 221
publisher
Oxford University Press
external identifiers
  • pmid:25567068
  • wos:000351601600009
  • scopus:84922433201
ISSN
1532-2092
DOI
10.1093/europace/euu342
language
English
LU publication?
yes
id
cc7a94dc-67f8-4d48-a478-021b5ff55ed9 (old id 5040966)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/25567068?dopt=Abstract
date added to LUP
2015-02-02 18:41:38
date last changed
2017-10-29 03:08:59
@article{cc7a94dc-67f8-4d48-a478-021b5ff55ed9,
  abstract     = {The Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Paroxysmal Atrial Fibrillation (MANTRA-PAF) trial assessed the long-term efficacy of an initial strategy of radiofrequency ablation (RFA) vs. antiarrhythmic drug therapy (AAD) as first-line treatment for patients with PAF. In this substudy, we evaluated the effect of these treatment modalities on the Health-Related Quality of Life (HRQoL) and symptom burden of patients at 12 and 24 months.},
  author       = {Walfridsson, H and Walfridsson, U and Nielsen, J Cosedis and Johannessen, A and Raatikainen, P and Janzon, M and Levin, L A and Aronsson, M and Hindricks, G and Kongstad Rasmussen, Ole and Pehrson, S and Englund, A and Hartikainen, J and Mortensen, L S and Hansen, P S},
  issn         = {1532-2092},
  language     = {eng},
  number       = {2},
  pages        = {215--221},
  publisher    = {Oxford University Press},
  series       = {Europace},
  title        = {Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation: results on health-related quality of life and symptom burden. The MANTRA-PAF trial.},
  url          = {http://dx.doi.org/10.1093/europace/euu342},
  volume       = {17},
  year         = {2015},
}